FADD and cancer: Our previous research has shown that TAT peptide-conjugated FADD protein is successfully delivered to cancer cells through the caveolar pathway of endocytosis [194] and induces apoptosis signaling, simultaneously targeting pro-tumorigenic and pro-inflammatory NF-κB signaling [195].